Literature DB >> 24511112

Repurposing to fight cancer: the metformin-prostate cancer connection.

Anna Azvolinsky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24511112     DOI: 10.1093/jnci/dju030

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  8 in total

1.  mTOR inhibitors for treatment of low-risk prostate cancer.

Authors:  Michael A Liss; Lanette Rickborn; John DiGiovanni; Dean Bacich; Linda A DeGraffenried; Manish Parihar; Ian M Thompson; Zelton Dave Sharp
Journal:  Med Hypotheses       Date:  2018-06-05       Impact factor: 1.538

2.  Effects of metformin, buformin, and phenformin on the post-initiation stage of chemically induced mammary carcinogenesis in the rat.

Authors:  Zongjian Zhu; Weiqin Jiang; Matthew D Thompson; Dimas Echeverria; John N McGinley; Henry J Thompson
Journal:  Cancer Prev Res (Phila)       Date:  2015-03-24

3.  Metformin Bicarbonate-Mediated Efficient RNAi for Precise Targeting of TP53 Deficiency in Colon and Rectal Cancers.

Authors:  Jiangsheng Xu; Yunhua Liu; Sheng Liu; Wenquan Ou; Alisa White; Samantha Stewart; Katherine H R Tkaczuk; Lee M Ellis; Jun Wan; Xiongbin Lu; Xiaoming He
Journal:  Nano Today       Date:  2022-02-01       Impact factor: 20.722

4.  Is reliance on mitochondrial respiration a "chink in the armor" of therapy-resistant cancer?

Authors:  Dieter A Wolf
Journal:  Cancer Cell       Date:  2014-12-08       Impact factor: 31.743

5.  Phenformin inhibits growth and epithelial-mesenchymal transition of ErbB2-overexpressing breast cancer cells through targeting the IGF1R pathway.

Authors:  Zhiying Guo; Ming Zhao; Erin W Howard; Qingxia Zhao; Amanda B Parris; Zhikun Ma; Xiaohe Yang
Journal:  Oncotarget       Date:  2017-07-22

6.  Effects of metformin and phenformin on apoptosis and epithelial-mesenchymal transition in chemoresistant rectal cancer.

Authors:  Ji-Hye Park; Young-Heon Kim; Eun Hyeh Park; Sun-Joo Lee; Hyewon Kim; Areumnuri Kim; Seung Bum Lee; Sehwan Shim; Hyosun Jang; Jae Kyung Myung; Sunhoo Park; Su-Jae Lee; Min Jung Kim
Journal:  Cancer Sci       Date:  2019-08-02       Impact factor: 6.716

7.  Metformin alleviates breast cancer through targeting high-mobility group AT-hook 2.

Authors:  Yang Li; Dan Wang; Hui Ren; Wei Feng
Journal:  Thorac Cancer       Date:  2020-02-07       Impact factor: 3.500

8.  Phenformin suppresses angiogenesis through the regulation of exosomal microRNA-1246 and microRNA-205 levels derived from oral squamous cell carcinoma cells.

Authors:  Dexuan Zhuang; Shuangshuang Wang; Guanyi Liu; Panpan Liu; Huiting Deng; Jianfeng Sun; Chang Liu; Xue Leng; Qun Zhang; Fuxiang Bai; Jun Mi; Xunwei Wu
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.